The Pharmacy Times® Eye Care resource center provides clinical news and articles, coverage from ophthalmology conferences and meetings, links to condition-specific resources, and videos and other content.
What can we help you find?
Brolucizumab is the most clinically advanced humanized single-chain antibody fragment. This type of antibody is highly sought after due to their small size, enhanced tissue penetration, rapid clearance from systemic circulation, and drug delivery characteristics.
Alembic Pharmaceuticals has received FDA approval for Dorzolamide Hydrochloride Ophthalmic Solution USP, 2%, therapeutically equivalent to Trusopt Ophthalmic Solution, 2% (Merck Sharp & Dohme Corp.).
Stephanie Conway, PharmD, RPh, Associate Professor at Massachusetts College of Pharmacy & Health Sciences—Worcester/Manchester, discusses best practices for encouraging collaboration between pharmacy and optometry students.
Stephanie Conway, PharmD, RPh, Associate Professor at Massachusetts College of Pharmacy & Health Sciences—Worcester, discusses the links between ophthalmic conditions, over-the-counter ophthalmic products, and pharmacists.
Kaelen C. Dunican, PharmD, Professor at MCPHS University—Worcester/Manchester, MA discusses an interprofessional, educational activity with pharmacy and optometry students for reviewing common, self-treatable ophthalmic conditions.
JK is experiencing gastrointestinal effects. What could be the cause?
Did you know that eyedrops are color-coded for patient safety and adherence?
Vector-based gene therapy shows efficacy treating glaucoma.
Daily eye drops may increase medication nonadherence in patients with glaucoma.
Stem cell exosomes observed to protect retinal cells in a recent study.
Observing retinal changes and treating patients with an anti-diabetic drug could protect against Parkinson’s disease progression.
Patients who received their prescriptions by mail were the least likely to be adherent.